Evidence map›Paper›PMID 31819262›Full record

ArticleNature2020

A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.

Senén D Mendoza, Eliza S Nieweglowska, Sutharsan Govindarajan, Lina M Leon, Joel D Berry, Anika Tiwari, Vorrapon Chaikeeratisak, Joe Pogliano, David A Agard, Joseph Bondy-Denomy

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 248 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. The biology of jumbo phages.Nature communications · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Lysis cassette of jumbophage PhiKZ.Scientific reports · 2026
    Article
  18. [Research on Bacteriophage Resistance: Coevolutionary Arms Race Between Bacteria and Phages Drives Novel Antibacterial Therapies].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  19. Review
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Senén D MendozaDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
Eliza S Nieweglowska *Howard Hughes Medical Institute, Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Sutharsan Govindarajan *Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
Lina M LeonDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
Joel D BerryDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
Anika TiwariDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
Vorrapon ChaikeeratisakDivision of Biological Sciences, University of California San Diego, La Jolla, CA, USA.
Joe PoglianoDivision of Biological Sciences, University of California San Diego, La Jolla, CA, USA.
David A AgardHoward Hughes Medical Institute, Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Joseph Bondy-DenomyDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. Joseph.Bondy-Denomy@ucsf.edu.
University of California, San Francisco · USUniversity of California, San Diego · USHoward Hughes Medical Institute · USQuantitative BioSciences · USSRM University · IN

Funding

GENETICS OF EUCARYOTIC AND PROCARYOTIC ORGANISMST32GM007810 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHRAFI, KAVEH, NARLIKAR, GEETA J · 1985 to 2020
$15.1M
Microbial Pathogenesis and Host DefenseT32AI060537 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joanne N. Engel · 2004 to 2026
$6.5M
Molecular and cellular biology of the phage nucleus and spindleR01GM129245 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POGLIANO, JOSEPH A · 2018 to 2025
$4.2M
Structure & Mechanism: microtubule nucleation, centrosomes, phage cytoskeletonR35GM118099 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGARD, DAVID A. · 2016 to 2022
$3.6M
Discovering New Roles for CRISPR-Cas in Bacterial PathogenesisDP5OD021344 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BONDY-DENOMY, JOSEPH · 2015 to 2019
$2.1M
Uncovering the mechanism and role of a widespread anti-CRISPR-Cas9 proteinR01GM127489 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BONDY-DENOMY, JOSEPH · 2018 to 2022
$1.7M
Characterization of a bacteriophage tubulin involved in viral replicationR01GM104556 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AGARD, DAVID A., POGLIANO, JOSEPH A · 2013 to 2016
$1.6M
Natiional Institutes of Health GM104556NIAID NIH HHS T32 AI060537NIGMS NIH HHS R01 GM104556NIGMS NIH HHS R01 GM127489NIGMS NIH HHS R01 GM129245NIGMS NIH HHS R35 GM118099NIGMS NIH HHS T32 GM007810NIH HHS DP5 OD021344
6 · The paper itself

Abstract

All viruses require strategies to inhibit or evade the immune pathways of cells that they infect. The viruses that infect bacteria, bacteriophages (phages), must avoid immune pathways that target nucleic acids, such as CRISPR-Cas and restriction-modification systems, to replicate efficiently

Indexed as

CRISPR-Associated ProteinsCRISPR-Cas SystemsDNA, ViralGenome, ViralPseudomonas aeruginosaPseudomonas PhagesViral ProteinsCRISPR-Associated ProteinsDNA, ViralViral Proteins

Identifiers

PMID31819262
PMCPMC6949375
OpenAlexW2991655268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.